…and some to hold, avoid or sell

BTG Sharecast

Jpmorgan has cut its target price for the UK pharma, citing lower sales of established drugs and problems with Pneumrx, its upcoming lung therapy. Full-year results in May will give a clearer picture. Hold. 633p.

DFS Furniture Investors Chronicle

The sofa retailer has been troubled by declining profits and investment requirements. But the dividend has been maintained, thanks to improved cost controls, and trading momentum is “positive”. Hold. 185p.

Greene King The Sunday Times

The pub group has a good track record and bullish management, but it’s been hit by tough trading and rises in the living wage and business rates, and is selling off assets. Avoid. 474.8p.

Next Fifteen Communications Investors Chronicle

The digital marketing group’s strong momentum faltered in 2017, but organic revenues have recovered and spending is under control. Recent acquisitions netted new global clients, including Cadbury and Honda. Hold. 450p.

Renew Holdings The Daily Telegraph

Shares in the engineering services and specialist housebuilding group have been volatile. But it is performing strongly with a promising order book, and debt should be eliminated by the year end. Hold. 388p.

Sophos Group The Daily Telegraph

Shares in the security software outfit were hammered after revenue growth slowed following the launch of a new product. But the firm is “an attractive acquisition target” and “can still grow at 15-20% a year”. Hold. 427.6p.